Market Cap (In EUR)
83.71 Million
Revenue (In EUR)
36.96 Million
Net Income (In EUR)
-11.3 Million
Avg. Volume
4575.00
- Currency
- EUR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 4.12-10.1
- PE
- -
- EPS
- -
- Beta Value
- 1.245
- ISIN
- DE000A3CMGM5
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Bruno Wohlschlegel
- Employee Count
- -
- Website
- https://apontis-pharma.de
- Ipo Date
- 2021-05-11
- Details
- Apontis Pharma AG markets and sells medical drugs for indication fields of internal medicine in Germany. It develops, promotes, and sells a portfolio of single pills and other pharmaceutical products with a focus on cardiovascular diseases, such as hypertension, hyperlipidemia, and secondary prevention, as well as respiratory diseases and diabetes. The company was founded in 1946 is headquartered in Monheim am Rhein, Germany.
More Stocks
-
CSSXF
-
SUNTECKSunteck Realty Limited
SUNTECK
-
KMAZ
-
MST
-
BOMBWIRBombay Wire Ropes Ltd
BOMBWIR
-
SHAHALLOYSShah Alloys Limited
SHAHALLOYS
-
UZAPFFlughafen Zürich AG
UZAPF
-
AIML